| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.83B | $757.3M | $1.95B |
| YoY Revenue Growth % | +141.5% | -61.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $535.0M | -$97.1M | $1.11B |
| Operating Margin % | 29.2% | -12.8% | 56.9% |
| Net Income (GAAP) | $341.1M | -$104.4M | $748.7M |
| EBITDA (Normalized) | $682.7M | -$55.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $464.6M | $220.7M | $291.4M |
| Capital Expenditures (CapEx) | $184.6M | $52.1M | — |
| Free Cash Flow (FCF) | $280.0M | $168.6M | $291.4M |
| FCF Margin % | 15.3% | 22.3% | 15.0% |
| Return on Invested Capital (ROIC %) | 11.5% | -4.1% | — |
| Cash & Short-Term Equivalents | $29.7M | $6.0M | — |
| Total Debt (Short + Long Term) | $2.72B | $1.50B | — |
| Total Stockholders' Equity | $984.1M | $400.1M | — |